Fady Ibraham Malik - 10 Dec 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ Robert Wong, attorney-in-fact for Dr. Malik
Issuer symbol
CYTK
Transactions as of
10 Dec 2024
Net transactions value
-$327,451
Form type
4
Filing time
10 Dec 2024, 17:42:56 UTC
Previous filing
05 Dec 2024
Next filing
10 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $42,188 +5,300 +4.5% $7.96 123,371 10 Dec 2024 Direct
transaction CYTK Common Stock Sale $268,339 -5,300 -4.3% $50.63 118,071 10 Dec 2024 Direct
transaction CYTK Common Stock Sale $101,300 -2,000 -1.7% $50.65 116,071 10 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -5,300 -100% $0.000000 0 10 Dec 2024 Common Stock 5,300 $7.96 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).